Maravai LifeSciences Holdings, Inc. MRVI Other long-term liabilities
Other long-term liabilities at other companies
Other financials
Where this comes from
Reported directly by Maravai LifeSciences Holdings, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities.
The official record: Maravai LifeSciences Holdings, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Maravai LifeSciences Holdings, Inc.'s other long-term liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Maravai LifeSciences Holdings, Inc.'s other long-term liabilities?
- Maravai LifeSciences Holdings, Inc. (MRVI) reported other long-term liabilities of -$203K in Q1 2026.
- How has Maravai LifeSciences Holdings, Inc.'s other long-term liabilities changed year-over-year?
- Maravai LifeSciences Holdings, Inc.'s other long-term liabilities increased by 97.6% year-over-year, from -$8.49M to -$203K.
- What is the long-term trend for Maravai LifeSciences Holdings, Inc.'s other long-term liabilities?
- Over 4 years (2021 to 2025), Maravai LifeSciences Holdings, Inc.'s other long-term liabilities has grown at a 42.5% compound annual growth rate (CAGR), from -$4.52M to -$18.63M.